UNCLAIMED
ValGenesis
Overview
ValGenesis is a software company based in the United States, founded in 2005, and employs between 501 and 1,000 individuals. The company specializes in business intelligence software and broader computer technology solutions. ValGenesis has recently published insights into the biosimilars market, highlighting the growth and complexity of this sector. Their document discusses the factors contributing to the rapid expansion of biosimilars, such as cost-effectiveness and the increasing prevalence of chronic diseases, alongside the pressure to reduce healthcare costs. The publication outlines the regulatory frameworks and methodologies required for the approval of biosimilars, emphasizing the importance of analytical comparisons between biosimilars and reference products to establish molecular similarity. It also addresses the challenges associated with demonstrating biosimilarity and the need for comprehensive analytical techniques to ensure product quality. This focus on the biosimilars market indicates ValGenesis's involvement in providing analytical solutions that support regulatory compliance and market readiness in the pharmaceutical industry.